Filtered By:
Specialty: Cardiology
Countries: China Health

This page shows you your search results in order of date. This is page number 10.

Order by Relevance | Date

Total 500 results found since Jan 2013.

Association  between pulse wave velocity and the 10-year risk of atherosclerotic cardiovascular disease in the Chinese population: A community-based study
In conclusion, baPWV and cfPWV are positively associated with the 10-year risk of ASCVD in the Chinese community-based population, with a nearly identical association with a high 10-year risk of ASCVD.PMID:36794419 | DOI:10.1111/jch.14642
Source: Atherosclerosis - February 16, 2023 Category: Cardiology Authors: Tieci Yi Lan Gao Fangfang Fan Yimeng Jiang Jia Jia Yan Zhang Jianping Li Yong Huo Source Type: research

Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation
CONCLUSION: THD plays a vital role in treating AS with multiple targets and pathways. Angiogenesis regulation, oxidative stress regulation, and immunity regulation consist of the crucial regulation cores in the mechanism. This study identified essential genes and pathways associated with the prognosis and pathogenesis of AS from new insights, demonstrating a feasible method for researching THD's chemical basis and pharmacology.PMID:36776258 | PMC:PMC9909180 | DOI:10.3389/fcvm.2023.1111475
Source: Atherosclerosis - February 13, 2023 Category: Cardiology Authors: SiJin Li Ping Liu Xiaoteng Feng Min Du Yifan Zhang YiRu Wang JiaRou Wang Source Type: research

Dual Antiplatelet Therapy Proves Mettle in Minor Stroke
(MedPage Today) -- DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute minor stroke who presented...
Source: MedPage Today Cardiovascular - February 13, 2023 Category: Cardiology Source Type: news

Tirofiban Improves Outcomes for Strokes With No Other Tx Options
(MedPage Today) -- DALLAS -- Tirofiban (Aggrastat) improved acute ischemic stroke outcomes for patients who weren't candidates for thrombolytic or endovascular treatment, according to a phase III trial from China. The glycoprotein IIb/IIIa inhibitor...
Source: MedPage Today Cardiovascular - February 11, 2023 Category: Cardiology Source Type: news

Tenecteplase on Par With Alteplase, Randomized Trial Affirms
(MedPage Today) -- DALLAS -- Tenecteplase (TNKase) did as good a job at ischemic stroke thrombolysis as did alteplase (Activase) for patients presenting within 4.5 hours of symptom onset in the randomized TRACE-2 trial from China. The proportion...
Source: MedPage Today Cardiovascular - February 9, 2023 Category: Cardiology Source Type: news

Inactivated whole-virion SARS-CoV-2 vaccines and long-term clinical outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study
CONCLUSIONS: Our results indicated no evidence of an increased ischemic or bleeding risk after vaccination with inactivated SARS-CoV-2 vaccine among Chinese patients with CAD, with limited statistical power.PMID:36756815 | DOI:10.1093/cvr/cvad031
Source: Atherosclerosis - February 9, 2023 Category: Cardiology Authors: Huajie Xu Jiaojiao Zheng Xin Zhao Qi Zhou Bing Fan Hongyi Wu Si Zhang Junbo Ge Source Type: research

Effectiveness and safety of the Trevo ® Retriever for mechanical thrombectomy in Chinese patients with acute ischemic stroke: Trevo Retriever China Registry
CONCLUSIONS: This real-world study of the Trevo Retriever in China demonstrated a high rate of revascularization and first-pass success that resulted in an overall high good function outcome rate and low mortality.PMID:36703568 | DOI:10.1177/15910199231151275
Source: Atherosclerosis - January 27, 2023 Category: Cardiology Authors: Xuelei Zhang Jinchao Liu Hongxing Han Pinyuan Zhang Xianglin Chen Haicheng Yuan Maohua Chen Qiyi Zhu David S Liebeskind Zhongrong Miao Trevo ® Retriever Registry China Investigators Source Type: research

3-Year outcomes after left atrial appendage closure in patients with nonvalvular atrial fibrillation: cardiomyopathy related with increased death and stroke rate
Left atrial appendage closure (LAAC) is a novel treatment for stroke prevention in high-risk patients with non-valvular atrial fibrillation (NVAF). However, the long-term outcomes after LAAC in Chinese NVAF pa...
Source: BMC Cardiovascular Disorders - January 17, 2023 Category: Cardiology Authors: Chunyu Chen, Yuyi Chen, Lulu Qu, Xi Su and Yanhong Chen Tags: Research Source Type: research

Differences in left and right carotid plaque vulnerability in patients with bilateral carotid plaques: a CARE-II study
CONCLUSIONS: There were asymmetries in plaque growth and evolution between BCPs. The left carotid plaques were more likely to have larger plaque burden, higher prevalence of LRNC and greater IPH volume, which may contribute to the lateralisation of ischaemic stroke in the cerebral hemispheres.PMID:36596656 | DOI:10.1136/svn-2022-001937
Source: Atherosclerosis - January 3, 2023 Category: Cardiology Authors: Sai Shao Honglu Shi Guangbin Wang Rui Li Qinjian Sun Bin Yao Hiroko Watase Daniel S Hippe Chun Yuan Xihai Zhao Investigators of CARE-II study Source Type: research

Association between polymorphisms in miRNAs and ischemic stroke: A meta-analysis
CONCLUSION: This Meta-analysis showed that all 4 single nucleotide polymorphisms were associated with the risk of IS or SAO, even though the overall and subgroup analyses were not entirely consistent.PMID:36596006 | PMC:PMC9803434 | DOI:10.1097/MD.0000000000032078
Source: Atherosclerosis - January 3, 2023 Category: Cardiology Authors: Yunnan Jing Siya Hu Jing Song Xu Dong Ying Zhang Xiaowei Sun Dongyan Wang Source Type: research

Treatment of progressive ischemic stroke with low ‑dose eptifibatide: A retrospective case‑control study
Exp Ther Med. 2022 Nov 22;25(1):22. doi: 10.3892/etm.2022.11721. eCollection 2023 Jan.ABSTRACTProgressive ischemic stroke (PIS) is a therapeutic challenge in clinical practice. The present retrospective study aimed to investigate the safety and effectiveness of eptifibatide in the treatment of PIS. The present study enrolled patients with PIS admitted to Xiangtan Central Hospital (Xiangtan, China) between March 2020 and March 2021 with National Institutes of Health Stroke Scale (NIHSS) progression scores of ≥2 points during the initial 72 h. Patients were then divided into two groups according to their different anti-pla...
Source: Atherosclerosis - December 23, 2022 Category: Cardiology Authors: Long Luo Jinsheng Lin Ye Deng Zhigang Li Ying Yuan Wen Zhang Source Type: research

P ‐wave durations from automated electrocardiogram analysis to predict atrial fibrillation and mortality in heart failure
ConclusionsExtreme values of maximum P-wave durations ( ≤90 ms and ≥141 ms) were significant predictors of new-onset AF, cardiovascular mortality, and all-cause mortality.
Source: ESC Heart Failure - December 3, 2022 Category: Cardiology Authors: Jiandong Zhou, Andrew Li, Martin Tan, Matthew Chung Yan Lam, Lok Tin Hung, Ronald Wing Hei Siu, Sharen Lee, Ishan Lakhani, Jeffrey Shi Kai Chan, Khalid Bin Waleed, Tong Liu, Kamalan Jeevaratnam, Qingpeng Zhang, Gary Tse Tags: Original Article Source Type: research